Weisel R D, Charlesworth D C, Mickleborough L L, Fremes S E, Ivanov J, Mickle D A, Teasdale S J, Glynn M F, Scully H E, Goldman B S
J Thorac Cardiovasc Surg. 1984 Jul;88(1):26-38.
Blood conservation has been most successful when blood salvage techniques have been combined with postoperative normovolemic hemodilution. The hemodynamic and myocardial metabolic responses to normovolemic hemodilution were assessed in a prospective randomized trial. Twenty-seven patients were randomized to receive either blood and colloid solutions (colloid group, 13 patients) or crystalloid fluids (crystalloid group, 14 patients) following elective coronary revascularization. Although seven patients in the crystalloid group received blood products when the hemoglobin level fell below 7 gm/dl, blood bank requirements were less in the crystalloid group (colloid, 3.6 +/- 1.2 L; crystalloid, 1.5 +/- 1.0 L, p less than 0.01). The crystalloid group received twice as much fluid to maintain normovolemia (left atrial pressure between 8 and 10 mm Hg) in the first 72 hours postoperatively (colloid, 6.5 +/- 1.9 L; crystalloid, 14.5 +/- 3.1 L, p less than 0.01). The infusion of large volumes of crystalloid fluids resulted in a progressive postoperative anemia (hemoglobin: colloid, 12.1 +/- 1.6 gm/dl, crystalloid 8.9 +/- 1.7 gm/dl, p less than 0.01, 20 hours postoperatively). Although the crystalloid-treated patients had peripheral edema, pulmonary edema could not be documented and there was no difference in the physiological shunt fractions between the two groups. Preload (left atrial pressure), afterload (mean arterial pressure), and cardiac index were similar in the two groups. The crystalloid group had a delayed recovery of myocardial oxygen and lactate extraction postoperatively. Volume loading and atrial pacing 3 to 5 hours postoperatively maintained myocardial lactate extraction in the colloid group but decreased myocardial lactate extraction to ischemic levels in the crystalloid group. The use of crystalloid rather than colloid fluids in the early postoperative period conserved blood products but resulted in postoperative anemia and was associated with a delay in myocardial metabolic recovery. Normovolemic hemodilution should be employed with caution in patients who are at risk of perioperative ischemic injury.
当血液回收技术与术后等容血液稀释相结合时,血液保护最为成功。在一项前瞻性随机试验中评估了等容血液稀释对血流动力学和心肌代谢的反应。27例患者在择期冠状动脉血运重建术后被随机分为两组,分别接受血液和胶体溶液(胶体组,13例患者)或晶体液(晶体组,14例患者)。尽管晶体组中有7例患者在血红蛋白水平降至7g/dl以下时接受了血液制品,但晶体组的血库需求量较少(胶体组,3.6±1.2L;晶体组,1.5±1.0L,p<0.01)。晶体组在术后最初72小时内需要输注两倍量的液体以维持等容状态(左心房压力在8至10mmHg之间)(胶体组,6.5±1.9L;晶体组,14.5±3.1L,p<0.01)。大量输注晶体液导致术后逐渐出现贫血(血红蛋白:胶体组,12.1±1.6g/dl,晶体组8.9±1.7g/dl,术后20小时,p<0.01)。尽管接受晶体液治疗的患者出现了外周水肿,但未发现肺水肿,两组间的生理分流分数也无差异。两组的前负荷(左心房压力)、后负荷(平均动脉压)和心脏指数相似。晶体组术后心肌氧摄取和乳酸摄取的恢复延迟。术后3至5小时进行容量负荷和心房起搏可维持胶体组的心肌乳酸摄取,但使晶体组的心肌乳酸摄取降至缺血水平。术后早期使用晶体液而非胶体液可节省血液制品,但会导致术后贫血,并与心肌代谢恢复延迟有关。对于有围手术期缺血损伤风险的患者,应谨慎使用等容血液稀释。